{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:23:53Z","timestamp":1790141033534,"version":"4.0.1"},"reference-count":305,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Oxidative stress (OS), generated by the overrun of reactive species of oxygen and nitrogen (RONS), is the key cause of several human diseases. With inflammation, OS is responsible for the onset and development of clinical signs and the pathological hallmarks of Alzheimer\u2019s disease (AD). AD is a multifactorial chronic neurodegenerative syndrome indicated by a form of progressive dementia associated with aging. While one-target drugs only soften its symptoms while generating drug resistance, multi-target polyphenols from fruits and vegetables, such as ellagitannins (ETs), ellagic acid (EA), and urolithins (UROs), having potent antioxidant and radical scavenging effects capable of counteracting OS, could be new green options to treat human degenerative diseases, thus representing hopeful alternatives and\/or adjuvants to one-target drugs to ameliorate AD. Unfortunately, in vivo ETs are not absorbed, while providing mainly ellagic acid (EA), which, due to its trivial water-solubility and first-pass effect, metabolizes in the intestine to yield UROs, or irreversible binding to cellular DNA and proteins, which have very low bioavailability, thus failing as a therapeutic in vivo. Currently, only UROs have confirmed the beneficial effect demonstrated in vitro by reaching tissues to the extent necessary for therapeutic outcomes. Unfortunately, upon the administration of food rich in ETs or ETs and EA, URO formation is affected by extreme interindividual variability that renders them unreliable as novel clinically usable drugs. Significant attention has therefore been paid specifically to multitarget EA, which is incessantly investigated as such or nanotechnologically manipulated to be a potential \u201clead compound\u201d with protective action toward AD. An overview of the multi-factorial and multi-target aspects that characterize AD and polyphenol activity, respectively, as well as the traditional and\/or innovative clinical treatments available to treat AD, constitutes the opening of this work. Upon focus on the pathophysiology of OS and on EA\u2019s chemical features and mechanisms leading to its antioxidant activity, an all-around updated analysis of the current EA-rich foods and EA involvement in the field of AD is provided. The possible clinical usage of EA to treat AD is discussed, reporting results of its applications in vitro, in vivo, and during clinical trials. A critical view of the need for more extensive use of the most rapid diagnostic methods to detect AD from its early symptoms is also included in this work.<\/jats:p>","DOI":"10.3390\/ijms26020844","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T06:53:32Z","timestamp":1737442412000},"page":"844","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Ellagic Acid: A Green Multi-Target Weapon That Reduces Oxidative Stress and Inflammation to Prevent and Improve the Condition of Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4630-4371","authenticated-orcid":false,"given":"Silvana","family":"Alfei","sequence":"first","affiliation":[{"name":"Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano, 4, 16148 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9868-6199","authenticated-orcid":false,"given":"Guendalina","family":"Zuccari","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano, 4, 16148 Genova, Italy"},{"name":"Laboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, Via G. Gaslini 5, 16147 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer\u2019s Disease in the United States and the Public Health Impact of Delaying Disease Onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"Am. J. Public Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/17474930241279888","article-title":"Vascular Cognitive Impairment and Dementia: Mechanisms, Treatment, and Future Directions","volume":"19","author":"Mok","year":"2024","journal-title":"Int. J. Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.20533","article-title":"A 10-item Smell Identification Scale Related to Risk for Alzheimer\u2019s Disease","volume":"58","author":"Tabert","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1468-1331.2006.01605.x","article-title":"Recommendations for the Diagnosis and Management of Alzheimer\u2019s Disease and Other Disorders Associated with Dementia: EFNS Guideline","volume":"14","author":"Waldemar","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.2174\/1381612826666201112144006","article-title":"Neuroprotective Effects of Ellagic Acid in Alzheimer\u2019s Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential","volume":"27","author":"Javaid","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","article-title":"The Importance of Neuritic Plaques and Tangles to the Development and Evolution of AD","volume":"62","author":"Tiraboschi","year":"2004","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-Target-Directed Ligands To Combat Neurodegenerative Diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acschemneuro.8b00069","article-title":"Alzheimer\u2019s Disease, the \u201cOne-Molecule, One-Target\u201d Paradigm, and the Multitarget Directed Ligand Approach","volume":"9","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e12385","DOI":"10.1002\/trc2.12385","article-title":"Alzheimer\u2019s Disease Drug Development Pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent Advances in Alzheimer\u2019s Disease: Mechanisms, Clinical Trials and New Drug Development Strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/ciia.2006.1.2.143","article-title":"Economic Considerations in the Management of Alzheimer\u2019s Disease","volume":"1","author":"Zhu","year":"2006","journal-title":"Clin. Interv. Aging"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lamptey, R.N.L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., and Singh, J. (2022). A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031851"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Patil, V.M., Masand, N., Gautam, V., Kaushik, S., and Wu, D. (2023). Multi-Target-Directed Ligand Approach in Anti-Alzheimer\u2019s Drug Discovery. Deciphering Drug Targets for Alzheimer\u2019s Disease, Springer Nature.","DOI":"10.1007\/978-981-99-2657-2_13"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111724","DOI":"10.1016\/j.ejmech.2019.111724","article-title":"Ellagic Acid a Multi-Target Bioactive Compound for Drug Discovery in CNS? A Narrative Review","volume":"183","author":"Alfei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/jf000404a","article-title":"Antioxidant Activity of Pomegranate Juice and Its Relationship with Phenolic Composition and Processing","volume":"48","author":"Gil","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1039\/c0fo00008f","article-title":"Comparison of the polyphenolic composition and antioxidant activity of European commercial fruit juices","volume":"1","author":"Borges","year":"2010","journal-title":"Food Funct."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Alfei, S., Marengo, B., and Zuccari, G. (2020). Oxidative Stress, Antioxidant Capabilities, and Bioavailability: Ellagic Acid or Urolithins?. Antioxidants, 9.","DOI":"10.3390\/antiox9080707"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1055\/s-0029-1185797","article-title":"Anti-Ischemic Activity and Endothelium-Dependent Vasorelaxant Effect of Hydrolysable Tannins from the Leaves of Rhus Coriaria (Sumac) in Isolated Rabbit Heart and Thoracic Aorta","volume":"75","author":"Beretta","year":"2009","journal-title":"Planta Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.mam.2010.09.005","article-title":"Ellagitannins, Ellagic Acid and Vascular Health","volume":"31","author":"Larrosa","year":"2010","journal-title":"Mol. Asp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jnutbio.2009.04.012","article-title":"Anti-Inflammatory Properties of a Pomegranate Extract and Its Metabolite Urolithin-A in a Colitis Rat Model and the Effect of Colon Inflammation on Phenolic Metabolism\u2606","volume":"21","author":"Larrosa","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinternmed.2009.38","article-title":"A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease","volume":"169","author":"Mente","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1007\/s13197-017-2672-y","article-title":"Antioxidant efficiency of polyphenols from coffee and coffee substitutes-electrochemical versus spectrophotometric approach","volume":"54","author":"Komes","year":"2017","journal-title":"J. Food Sci. Technol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.saa.2014.04.052","article-title":"Spectroscopic Studies on the Antioxidant Activity of Ellagic Acid","volume":"130","author":"Kilic","year":"2014","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Castellani, R.J., Plascencia-Villa, G., and Perry, G. (2021). Pathogenesis of Alzheimer\u2019s Disease. Handbook of Neurotoxicity, Springer International Publishing.","DOI":"10.1007\/978-3-030-71519-9_162-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The Neuropathological Diagnosis of Alzheimer\u2019s Disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijbiomac.2022.11.031","article-title":"Protein Misfolding and Related Human Diseases: A Comprehensive Review of Toxicity, Proteins Involved, and Current Therapeutic Strategies","volume":"223","author":"Khan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Majid, N., and Khan, R.H. (2023). Protein Aggregation: Consequences, Mechanism, Characterization and Inhibitory Strategies. Int. J. Biol. Macromol., 242.","DOI":"10.1016\/j.ijbiomac.2023.125123"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","article-title":"Amyloid Oligomers: A Joint Experimental\/Computational Perspective on Alzheimer\u2019s Disease, Parkinson\u2019s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis","volume":"121","author":"Nguyen","year":"2021","journal-title":"Chem. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Schrank, S., Barrington, N., and Stutzmann, G.E. (2020). Calcium-Handling Defects and Neurodegenerative Disease. Cold Spring Harb. Perspect. Biol., 12.","DOI":"10.1101\/cshperspect.a035212"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Alfei, S., Schito, G.C., Schito, A.M., and Zuccari, G. (2024). Reactive Oxygen Species (ROS)-Mediated Antibacterial Oxidative Therapies: Available Methods to Generate ROS and a Novel Option Proposal. IJMS, 25.","DOI":"10.20944\/preprints202405.1628.v1"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/acs.jmedchem.7b00393","article-title":"BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer\u2019s Disease","volume":"61","author":"Prati","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/DDDT.S257494","article-title":"Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases","volume":"14","author":"Makhoba","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Morat\u00f3, X., Pytel, V., Jofresa, S., Ruiz, A., and Boada, M. (2022). Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer\u2019s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169305"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107934","DOI":"10.1016\/j.pharmthera.2021.107934","article-title":"New Approaches for Developing Multi-Targeted Drug Combinations for Disease Modification of Complex Brain Disorders. Does Epilepsy Prevention Become a Realistic Goal?","volume":"229","author":"Klein","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Abatematteo, F.S., Niso, M., Contino, M., Leopoldo, M., and Abate, C. (2021). Multi-Target Directed Ligands (MTDLs) Binding the \u03a31 Receptor as Promising Therapeutics: State of the Art and Perspectives. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126359"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Alfei, S., Giannoni, P., Signorello, M.G., Torazza, C., Zuccari, G., Athanassopoulos, C.M., Domenicotti, C., and Marengo, B. (2024). The Remarkable and Selective In Vitro Cytotoxicity of Synthesized Bola-Amphiphilic Nanovesicles on Etoposide-Sensitive and -Resistant Neuroblastoma Cells. Nanomaterials, 14.","DOI":"10.20944\/preprints202408.0465.v1"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed Multiple Ligands. An Emerging Drug Discovery Paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drudis.2006.12.006","article-title":"Fragments, Network Biology and Designing Multiple Ligands","volume":"12","author":"Morphy","year":"2007","journal-title":"Drug Discov. Today"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","article-title":"From Magic Bullets to Designed Multiple Ligands","volume":"9","author":"Morphy","year":"2004","journal-title":"Drug Discov. Today"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/13543776.2021.1874344","article-title":"Acetylcholinesterase Inhibitors for the Treatment of Alzheimer\u2019s Disease\u2014A Patent Review (2016\u2013Present)","volume":"31","author":"Bortolami","year":"2021","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/13543784.2016.1216972","article-title":"Old and New Acetylcholinesterase Inhibitors for Alzheimer\u2019s Disease","volume":"25","author":"Galimberti","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amjopharm.2012.08.002","article-title":"The Effect of HMG-CoA Reductase Inhibitors on Cognition in Patients With Alzheimer\u2019s Dementia: A Prospective Withdrawal and Rechallenge Pilot Study","volume":"10","author":"Padala","year":"2012","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer\u2019s Disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized Trial of Verubecestat for Prodromal Alzheimer\u2019s Disease","volume":"380","author":"Egan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMc1813435","article-title":"Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer\u2019s Disease","volume":"380","author":"Henley","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamaneurol.2019.3988","article-title":"Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease","volume":"77","author":"Wessels","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/ADR-210296","article-title":"Phase II (NAVIGATE-AD Study) Results of LY3202626 Effects on Patients with Mild Alzheimer\u2019s Disease Dementia","volume":"5","author":"Lo","year":"2021","journal-title":"J. Alzheimers Dis. Rep."},{"key":"ref_48","unstructured":"ClinicalTrials.gov (2021). A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer\u2019s Disease."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Iraji, A., Khoshneviszadeh, M., Firuzi, O., Khoshneviszadeh, M., and Edraki, N. (2020). Novel Small Molecule Therapeutic Agents for Alzheimer Disease: Focusing on BACE1 and Multi-Target Directed Ligands. Bioorg. Chem., 97.","DOI":"10.1016\/j.bioorg.2020.103649"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/13543784.2019.1683160","article-title":"Investigational BACE Inhibitors for the Treatment of Alzheimer\u2019s Disease","volume":"28","author":"Imbimbo","year":"2019","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A Phase 3 Trial of Semagacestat for Treatment of Alzheimer\u2019s Disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","article-title":"Targeting Prodromal Alzheimer Disease With Avagacestat","volume":"72","author":"Coric","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2009.1866","article-title":"Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease: A Randomized Controlled Trial","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A\u03b2 Amyloid Deposition and Toxicity in Alzheimer Disease","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, Efficacy, and Biomarker Findings of PBT2 in Targeting A\u03b2 as a Modifying Therapy for Alzheimer\u2019s Disease: A Phase IIa, Double-Blind, Randomised, Placebo-Controlled Trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.trci.2017.10.001","article-title":"A Randomized, Exploratory Molecular Imaging Study Targeting Amyloid \u03b2 with a Novel 8-OH Quinoline in Alzheimer\u2019s Disease: The PBT2-204 IMAGINE Study","volume":"3","author":"Villemagne","year":"2017","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Mantile, F., and Prisco, A. (2020). Vaccination against \u03b2-Amyloid as a Strategy for the Prevention of Alzheimer\u2019s Disease. Biology, 9.","DOI":"10.3390\/biology9120425"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, Gantenerumab, BAN2401, and ALZ-801\u2014The First Wave of Amyloid-Targeting Drugs for Alzheimer\u2019s Disease with Potential for near Term Approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","article-title":"A Phase III Randomized Trial of Gantenerumab in Prodromal Alzheimer\u2019s Disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41582-019-0295-9","article-title":"Questions EMERGE as Biogen Claims Aducanumab Turnaround","volume":"16","author":"Howard","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2021.3854","article-title":"Evaluation of Aducanumab for Alzheimer Disease","volume":"325","author":"Alexander","year":"2021","journal-title":"JAMA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-160544","article-title":"A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer\u2019s Disease","volume":"54","author":"Malpas","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s13311-018-0662-z","article-title":"Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer\u2019s Disease","volume":"16","author":"Cardoso","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jbiotec.2015.02.032","article-title":"Discovery and Development of Seliciclib. How Systems Biology Approaches Can Lead to Better Drug Performance","volume":"202","author":"Khalil","year":"2015","journal-title":"J. Biotechnol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2016.02.007","article-title":"The Antineoplastic Drug Flavopiridol Reverses Memory Impairment Induced by Amyloid-\u00df 1-42 Oligomers in Mice","volume":"106","author":"Leggio","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A Phase II Trial of Tideglusib in Alzheimer\u2019s Disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_67","first-page":"104","article-title":"Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer\u2019s Disease","volume":"10","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a Treatment for Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"48","author":"Matsunaga","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1192\/bjp.2019.76","article-title":"Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: Randomised clinical trial","volume":"215","author":"Forlenza","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-142874","article-title":"Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer\u2019s Disease","volume":"44","author":"Wischik","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and Safety of Tau-Aggregation Inhibitor Therapy in Patients with Mild or Moderate Alzheimer\u2019s Disease: A Randomised, Controlled, Double-Blind, Parallel-Arm, Phase 3 Trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0269881114552744","article-title":"Investigation of the Effects of Solid Lipid Curcumin on Cognition and Mood in a Healthy Older Population","volume":"29","author":"Cox","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"ref_73","unstructured":"ClinicalTrials.gov (2015). Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects with Mild Alzheimer\u2019s Disease."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000348347","article-title":"A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment","volume":"35","author":"Morimoto","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2174\/156720509789207895","article-title":"Addressing Alzheimers Disease Tangles: From NAP to AL-108","volume":"6","author":"Gozes","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamaneurol.2019.3812","article-title":"Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome","volume":"77","author":"Tsai","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_77","unstructured":"ClinicalTrials.gov (2015). 24 Months Safety and Efficacy Study of AADvac1 in Patients with Mild Alzheimer\u2019s Disease."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-Targeting Therapies for Alzheimer Disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/1673-5374.266061","article-title":"Early Active Immunization with A\u03b23\u201310-KLH Vaccine Reduces Tau Phosphorylation in the Hippocampus and Protects Cognition of Mice","volume":"15","author":"Wang","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_80","unstructured":"ClinicalTrials.gov (2020). Phase 2 Study of BIIB092 in Participants with Early Alzheimer\u2019s Disease."},{"key":"ref_81","unstructured":"ClinicalTrials.gov (2019). A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer\u2019s Disease."},{"key":"ref_82","unstructured":"ClinicalTrials.gov (2020). An Extension Study of ABBV-8E12 in Early Alzheimer\u2019s Disease (AD)."},{"key":"ref_83","unstructured":"ClinicalTrials.gov (2022). A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients with Prodromal to Mild Alzheimer\u2019s Disease."},{"key":"ref_84","unstructured":"ClinicalTrials.gov (2024). A Study of Semorinemab in Patients with Moderate Alzheimer\u2019s Disease."},{"key":"ref_85","unstructured":"ClinicalTrials.gov (2020). Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants with Alzheimer\u2019s Disease."},{"key":"ref_86","unstructured":"ClinicalTrials.gov (2022). A Study of LY3303560 in Participants with Early Symptomatic Alzheimer\u2019s Disease."},{"key":"ref_87","unstructured":"ClinicalTrials.gov (2025). A Study of JNJ-63733657 in Participants with Early Alzheimer\u2019s Disease."},{"key":"ref_88","unstructured":"ClinicalTrials.gov (2019). A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-018-1911-2","article-title":"Epitope Determines Efficacy of Therapeutic Anti-Tau Antibodies in a Functional Assay with Human Alzheimer Tau","volume":"136","author":"Courade","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Chen, Y., Xu, C., Zhang, H., and Lin, C. (2020). TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.602508"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awv379","article-title":"Pharmacological Targeting of CSF1R Inhibits Microglial Proliferation and Prevents the Progression of Alzheimer\u2019s-like Pathology","volume":"139","author":"Schetters","year":"2016","journal-title":"Brain"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/brain\/awz241","article-title":"CSF1R Inhibitor JNJ-40346527 Attenuates Microglial Proliferation and Neurodegeneration in P301S Mice","volume":"142","author":"Mancuso","year":"2019","journal-title":"Brain"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","article-title":"Early Long-Term Administration of the CSF1R Inhibitor PLX3397 Ablates Microglia and Reduces Accumulation of Intraneuronal Amyloid, Neuritic Plaque Deposition and Pre-Fibrillar Oligomers in 5XFAD Mouse Model of Alzheimer\u2019s Disease","volume":"13","author":"Sosna","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jphs.2020.05.009","article-title":"Inhibition of STAT3 Phosphorylation Attenuates Impairments in Learning and Memory in 5XFAD Mice, an Animal Model of Alzheimer\u2019s Disease","volume":"143","author":"Choi","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"ref_95","unstructured":"ClinicalTrials.gov (2021). A Pilot Open Labeled Study of Tacrolimus in Alzheimer\u2019s Disease."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/revneuro-2018-0008","article-title":"Role of P38\/MAPKs in Alzheimer\u2019s Disease: Implications for Amyloid Beta Toxicity Targeted Therapy","volume":"30","author":"Kheiri","year":"2018","journal-title":"Rev. Neurosci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-016-0221-y","article-title":"Selective Suppression of the \u03b1 Isoform of P38 MAPK Rescues Late-Stage Tau Pathology","volume":"8","author":"Maphis","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13195-020-00617-2","article-title":"A Selective P38\u03b1\/\u03b2 MAPK Inhibitor Alleviates Neuropathology and Cognitive Impairment, and Modulates Microglia Function in 5XFAD Mouse","volume":"12","author":"Gee","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.20171487","article-title":"P2Y1 Receptor Blockade Normalizes Network Dysfunction and Cognition in an Alzheimer\u2019s Disease Model","volume":"215","author":"Reichenbach","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer\u2019s Disease Biomarkers: A Pilot Clinical Trial","volume":"57","author":"Craft","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00415-018-8768-0","article-title":"Intranasal Insulin in Alzheimer\u2019s Dementia or Mild Cognitive Impairment: A Systematic Review","volume":"265","author":"Avgerinos","year":"2018","journal-title":"J. Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gejl, M., Gjedde, A., Egefjord, L., M\u00f8ller, A., Hansen, S.B., Vang, K., Rodell, A., Br\u00e6ndgaard, H., Gottrup, H., and Schacht, A. (2016). In Alzheimer\u2019s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Front. Aging Neurosci., 8.","DOI":"10.3389\/fnagi.2016.00108"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-150493","article-title":"Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial","volume":"51","author":"Luchsinger","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","article-title":"Effects of the Insulin Sensitizer Metformin in Alzheimer Disease","volume":"31","author":"Koenig","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11064-020-02993-5","article-title":"The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer\u2019s Disease and Other Neurodegenerative Disorders","volume":"45","author":"Strosznajder","year":"2020","journal-title":"Neurochem. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-\u03b3 Agonist Pioglitazone in Mild Alzheimer Disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_108","unstructured":"ClinicalTrials.gov (2019). AD-4833\/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants with Mild Cognitive Impairment Due to Alzheimer Disease."},{"key":"ref_109","unstructured":"ClinicalTrials.gov (2019). Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer\u2019s Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.13188\/2376-922X.1000025","article-title":"Therapeutic Advantages of Dual Targeting of PPAR-\u03b4 and PPAR-\u03b3 in an Experimental Model of Sporadic Alzheimer\u2019s Disease","volume":"5","author":"Reich","year":"2018","journal-title":"J. Park. Dis. Alzheimers Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13195-020-00678-3","article-title":"A Phase II Randomized Trial of Sodium Oligomannate in Alzheimer\u2019s Dementia","volume":"12","author":"Wang","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-021-00795-7","article-title":"A 36-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial of Sodium Oligomannate for Mild-to-Moderate Alzheimer\u2019s Dementia","volume":"13","author":"Xiao","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"ref_113","unstructured":"ClinicalTrials.gov (2024). Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer\u2019s Disease."},{"key":"ref_114","unstructured":"ClinicalTrials.gov (2020). Nighttime Agitation and Restless Legs Syndrome in People with Alzheimer\u2019s Disease."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2013.08.010","article-title":"Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"75","author":"Lin","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ijnp\/pyab001","article-title":"Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial","volume":"24","author":"Lane","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e216156","DOI":"10.1001\/jamanetworkopen.2021.6156","article-title":"Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia","volume":"4","author":"Lin","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_118","unstructured":"ClinicalTrials.gov (2021). Riluzole in Mild Alzheimer\u2019s Disease."},{"key":"ref_119","unstructured":"ClinicalTrials.gov (2023). Study of BHV-4157 in Alzheimer\u2019s Disease."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"ref_121","unstructured":"ClinicalTrials.gov (2024). DHA Brain Delivery Trial (PreventE4)."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"J54","DOI":"10.1093\/eurheartj\/suaa119","article-title":"Beyond Cardiovascular Medicine: Potential Future Uses of Icosapent Ethyl","volume":"22","author":"Bhatt","year":"2020","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(23)00274-0","article-title":"Preparing for Disease-Modifying Therapies in Alzheimer\u2019s Disease","volume":"22","author":"Belder","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e12377","DOI":"10.1002\/trc2.12377","article-title":"ARIA in Patients Treated with Lecanemab (BAN2401) in a Phase 2 Study in Early Alzheimer\u2019s Disease","volume":"9","author":"Honig","year":"2023","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1517\/13543776.18.4.387","article-title":"Progress in Acetylcholinesterase Inhibitors for Alzheimer\u2019s Disease: An Update","volume":"18","author":"Tumiatti","year":"2008","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_126","unstructured":"Myriad Genetics (2005). Pharmaceutical Methods, Dosing Regimes and Dosage for the Treatment of Alzheimer\u2019s Disease, Myriad Genetics Inc."},{"key":"ref_127","unstructured":"Koo, E.M., Golde, T., Galasko, D., and Weggen, S. (2006). Mayo Foundation for Medical Education and Research Method of Reducing Abeta42 and Treating Diseases, University of California."},{"key":"ref_128","unstructured":"Dainippon Sumitomo Pharma Co., Ltd. (2005). Medicine Comprising Combination of Acetylcholine Esterase Inhibitor and 5-Substituted 2-Oxadiazolyl-1,6-Naphthyridin-2(1H)-One Derivative, Dainippon Sumitomo Pharma Co., Ltd."},{"key":"ref_129","unstructured":"Gallagher, M. (2005). Method for Improving Cognitive Function by Co-Administration of a GABAB Receptor Antagonist and an Acetylcholinesterase Inhibitor, Pfizer Inc."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.12659\/MSM.892542","article-title":"Guidelines for prevention and treatment of cognitive impairment in the elderly","volume":"21","author":"Brodziak","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_131","unstructured":"Huang, Y., Li, G., and Stamford, A. (2006). Substituted Amide Beta Secretase Inhibitors. (US20060040994A1), U.S. Patent."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1021\/jm060884i","article-title":"Macrocyclic inhibitors of beta-secretase: Functional activity in an animal model","volume":"49","author":"Stachel","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_133","unstructured":"Gregory, C.W., and Smith, S.P. (2006). Leuprolide Acetate and Acetylcholinesterase Inhibitors\/NMDA Receptor Antagonists for the Treatment of Alzheimer\u2019s Disease. (WO2006071274A2)."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Yu, T.-W., Lane, H.-Y., and Lin, C.-H. (2021). Novel Therapeutic Approaches for Alzheimer\u2019s Disease: An Updated Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158208"},{"key":"ref_135","unstructured":"Salituro, F.G., and Robichaud, A.J. (2020). Compositions and Methods for Treating CNS Disorders. (US20200291059A1), U.S. Patent."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1479-8301.2007.00212.x","article-title":"Cognitive rehabilitation and cognitive training for mild dementia","volume":"7","author":"Mimura","year":"2007","journal-title":"Psychogeriatrics"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer\u2019s Disease","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox. Res."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Lazarus, A.A. (2001). Multimodal Therapy in Clinical Psychology. International Encyclopedia of the Social & Behavioral Sciences, Elsevier.","DOI":"10.1016\/B0-08-043076-7\/01303-6"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"111572","DOI":"10.1016\/j.ejmech.2019.111572","article-title":"The Chemistry Toolbox of Multitarget-Directed Ligands for Alzheimer\u2019s Disease","volume":"181","author":"Mesiti","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.2174\/1568026617666170717114944","article-title":"Therapeutic Agents in Alzheimer\u2019s Disease Through a Multi-Targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core","volume":"17","author":"Lin","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1039\/D4MD00550C","article-title":"Mannich Reaction Mediated Derivatization of Chromones and Their Biological Evaluations as Putative Multipotent Ligands for the Treatment of Alzheimer\u2019s Disease","volume":"15","author":"Kumar","year":"2024","journal-title":"RSC Med. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.2174\/0929867325666180111101843","article-title":"Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer\u2019s Disease: An Update","volume":"25","author":"Dias","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/jf802418j","article-title":"Coffee and Green Tea As a Large Source of Antioxidant Polyphenols in the Japanese Population","volume":"57","author":"Fukushima","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2174\/1381612822666160125114503","article-title":"Insights Into Effects of Ellagic Acid on the Nervous System: A Mini Review","volume":"22","author":"Ahmed","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Heber, D., Schulman, R.N., and Seeram, N.P. (2006). Pomegranates: Ancient Roots to Modern Medicine, CRC Press. [1st ed.].","DOI":"10.1201\/9781420009866"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.foodres.2014.09.003","article-title":"Profiling Ellagic Acid Content: The Importance of Form and Ascorbic Acid Levels","volume":"66","author":"Williams","year":"2014","journal-title":"Food Res. Int."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Gan, R.-Y., Chan, C.-L., Yang, Q.-Q., Li, H.-B., Zhang, D., Ge, Y.-Y., Gunaratne, A., Ge, J., and Corke, H. (2019). Bioactive Compounds and Beneficial Functions of Sprouted Grains. Sprouted Grains, Elsevier.","DOI":"10.1016\/B978-0-12-811525-1.00009-9"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1021\/jf010192x","article-title":"Effect of Processing and Storage on the Antioxidant Ellagic Acid Derivatives and Flavonoids of Red Raspberry (Rubus idaeus) Jams","volume":"49","author":"Zafrilla","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jff.2015.09.019","article-title":"Identifying the Limits for Ellagic Acid Bioavailability: A Crossover Pharmacokinetic Study in Healthy Volunteers after Consumption of Pomegranate Extracts","volume":"19","author":"Zafrilla","year":"2015","journal-title":"J. Funct. Foods"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Al-Harbi, S.A., Abdulrahman, A.O., Zamzami, M.A., and Khan, M.I. (2021). Urolithins: The Gut Based Polyphenol Metabolites of Ellagitannins in Cancer Prevention, a Review. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.647582"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e2101019","DOI":"10.1002\/mnfr.202101019","article-title":"Urolithins: A Comprehensive Update on Their Metabolism, Bioactivity, and Associated Gut Microbiota","volume":"66","author":"Selma","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1055\/a-0633-9492","article-title":"A Pharmacological Update of Ellagic Acid","volume":"84","author":"Giner","year":"2018","journal-title":"Planta Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cofs.2016.02.002","article-title":"Dietary Polyphenols, Oxidative Stress and Antioxidant and Anti-Inflammatory Effects","volume":"8","author":"Zhang","year":"2016","journal-title":"Curr. Opin. Food Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1500901","DOI":"10.1002\/mnfr.201500901","article-title":"Urolithins, the rescue of \u201cold\u201d metabolites to understand a \u201cnew\u201d concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status","volume":"61","author":"Selma","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1016\/j.bmcl.2011.07.086","article-title":"In Vivo Anti-Inflammatory and Antioxidant Properties of Ellagitannin Metabolite Urolithin A","volume":"21","author":"Ishimoto","year":"2011","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-017-0561-3","article-title":"In Vivo Administration of Urolithin A and B Prevents the Occurrence of Cardiac Dysfunction in Streptozotocin-Induced Diabetic Rats","volume":"16","author":"Savi","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/jpet.117.242420","article-title":"Urolithin A Mitigates Cisplatin-Induced Nephrotoxicity by Inhibiting Renal Inflammation and Apoptosis in an Experimental Rat Model","volume":"363","author":"Guada","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41467-018-07859-7","article-title":"Enhancement of the Gut Barrier Integrity by a Microbial Metabolite through the Nrf2 Pathway","volume":"10","author":"Singh","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"F1255","DOI":"10.1152\/ajprenal.00346.2019","article-title":"Oral Delivery of Nanoparticle Urolithin A Normalizes Cellular Stress and Improves Survival in Mouse Model of Cisplatin-Induced AKI","volume":"317","author":"Zou","year":"2019","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"104655","DOI":"10.1016\/j.phrs.2020.104655","article-title":"Urolithin B, a Gut Microbiota Metabolite, Protects against Myocardial Ischemia\/Reperfusion Injury via P62\/Keap1\/Nrf2 Signaling Pathway","volume":"153","author":"Zheng","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s13311-019-00753-0","article-title":"Activation of the MiR-34a-Mediated SIRT1\/MTOR Signaling Pathway by Urolithin A Attenuates d-Galactose-Induced Brain Aging in Mice","volume":"16","author":"Chen","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.fct.2019.04.031","article-title":"Protective Effect of Urolithin a on Cisplatin-Induced Nephrotoxicity in Mice via Modulation of Inflammation and Oxidative Stress","volume":"129","author":"Jing","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2000091","DOI":"10.1002\/mnfr.202000091","article-title":"Ellagic Acid and Its Microbial Metabolite Urolithin A Alleviate Diet-Induced Insulin Resistance in Mice","volume":"64","author":"Yang","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/acschemneuro.5b00260","article-title":"Pomegranate\u2019s Neuroprotective Effects against Alzheimer\u2019s Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites","volume":"7","author":"Yuan","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12974-019-1450-3","article-title":"Urolithin A Attenuates Memory Impairment and Neuroinflammation in APP\/PS1 Mice","volume":"16","author":"Gong","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1039\/C9FO01332F","article-title":"Urolithin A Targets the PI3K\/Akt\/NF-\u039aB Pathways and Prevents IL-1\u03b2-Induced Inflammatory Response in Human Osteoarthritis: In Vitro and in Vivo Studies","volume":"10","author":"Fu","year":"2019","journal-title":"Food Funct."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/cns.13136","article-title":"Urolithin A-activated Autophagy but Not Mitophagy Protects against Ischemic Neuronal Injury by Inhibiting ER Stress in Vitro and in Vivo","volume":"25","author":"Ahsan","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Ghosh, N., Das, A., Biswas, N., Gnyawali, S., Singh, K., Gorain, M., Polcyn, C., Khanna, S., Roy, S., and Sen, C.K. (2020). Urolithin A Augments Angiogenic Pathways in Skeletal Muscle by Bolstering NAD+ and SIRT1. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-76564-7"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41418-020-0593-1","article-title":"Urolithin A Suppresses High Glucose-Induced Neuronal Amyloidogenesis by Modulating TGM2-Dependent ER-Mitochondria Contacts and Calcium Homeostasis","volume":"28","author":"Lee","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbrc.2017.03.119","article-title":"Urolithin A Alleviates Myocardial Ischemia\/Reperfusion Injury via PI3K\/Akt Pathway","volume":"486","author":"Tang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.pharep.2017.04.020","article-title":"Urolithin A Shows Anti-Atherosclerotic Activity via Activation of Class B Scavenger Receptor and Activation of Nef2 Signaling Pathway","volume":"70","author":"Cui","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e1800887","DOI":"10.1002\/mnfr.201800887","article-title":"A Novel Candidate for Prevention and Treatment of Atherosclerosis: Urolithin B Decreases Lipid Plaque Deposition in ApoE\u2212\/\u2212 Mice and Increases Early Stages of Reverse Cholesterol Transport in Ox-LDL Treated Macrophages Cells","volume":"63","author":"Zhao","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/oby.22404","article-title":"Urolithin A, a Gut Metabolite, Improves Insulin Sensitivity Through Augmentation of Mitochondrial Function and Biogenesis","volume":"27","author":"Toney","year":"2019","journal-title":"Obesity"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Mousavi, S., Weschka, D., Bereswill, S., and Heimesaat, M.M. (2021). Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis. Pathogens, 10.","DOI":"10.3390\/pathogens10070818"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2147\/DMSO.S268146","article-title":"Urolithins Attenuate Multiple Symptoms of Obesity in Rats Fed on a High-Fat Diet","volume":"13","author":"Abdulrahman","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/09637486.2021.1886255","article-title":"Effects of Urolithins on Obesity-Associated Gut Dysbiosis in Rats Fed on a High-Fat Diet","volume":"72","author":"Abdulrahman","year":"2021","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Adachi, S., Sasaki, K., Kondo, S., Komatsu, W., Yoshizawa, F., Isoda, H., and Yagasaki, K. (2020). Antihyperuricemic Effect of Urolithin A in Cultured Hepatocytes and Model Mice. Molecules, 25.","DOI":"10.3390\/molecules25215136"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroscience.2020.09.027","article-title":"Urolithin A Prevents Focal Cerebral Ischemic Injury via Attenuating Apoptosis and Neuroinflammation in Mice","volume":"448","author":"Lin","year":"2020","journal-title":"Neuroscience"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Shen, P.-X., Li, X., Deng, S.-Y., Zhao, L., Zhang, Y.-Y., Deng, X., Han, B., Yu, J., Li, Y., and Wang, Z.-Z. (2021). Urolithin A Ameliorates Experimental Autoimmune Encephalomyelitis by Targeting Aryl Hydrocarbon Receptor. EBioMedicine, 64.","DOI":"10.1016\/j.ebiom.2021.103227"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm.4132","article-title":"Urolithin A Induces Mitophagy and Prolongs Lifespan in C. Elegans and Increases Muscle Function in Rodents","volume":"22","author":"Ryu","year":"2016","journal-title":"Nat. Med."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Liu, H., Kang, H., Song, C., Lei, Z., Li, L., Guo, J., Xu, Y., Guan, H., Fang, Z., and Li, F. (2018). Urolithin A Inhibits the Catabolic Effect of TNF\u03b1 on Nucleus Pulposus Cell and Alleviates Intervertebral Disc Degeneration in Vivo. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01043"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/mc.22848","article-title":"A Natural Molecule, Urolithin A, Downregulates Androgen Receptor Activation and Suppresses Growth of Prostate Cancer","volume":"57","author":"Dahiya","year":"2018","journal-title":"Mol. Carcinog."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"17273","DOI":"10.1002\/jcb.28989","article-title":"Urolithin B Suppresses Tumor Growth in Hepatocellular Carcinoma through Inducing the Inactivation of Wnt\/\u0392-catenin Signaling","volume":"120","author":"Lv","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Xia, B., Shi, X.C., Xie, B.C., Zhu, M.Q., Chen, Y., Chu, X.Y., Cai, G.H., Liu, M., Yang, S.Z., and Mitchell, G.A. (2020). Urolithin A Exerts Antiobesity Effects through Enhancing Adipose Tissue Thermogenesis in Mice. PLoS Biol., 18.","DOI":"10.1371\/journal.pbio.3000688"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"112479","DOI":"10.1016\/j.jep.2019.112479","article-title":"Pancreas Protective Effects of Urolithin A on Type 2 Diabetic Mice Induced by High Fat and Streptozotocin via Regulating Autophagy and AKT\/MTOR Signaling Pathway","volume":"250","author":"Tuohetaerbaike","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Wang, Y., Jasper, H., Toan, S., Muid, D., Chang, X., and Zhou, H. (2021). Mitophagy Coordinates the Mitochondrial Unfolded Protein Response to Attenuate Inflammation-Mediated Myocardial Injury. Redox Biol., 45.","DOI":"10.1016\/j.redox.2021.102049"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"eabb0319","DOI":"10.1126\/scitranslmed.abb0319","article-title":"Urolithin A Improves Muscle Function by Inducing Mitophagy in Muscular Dystrophy","volume":"13","author":"Luan","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Zuccari, G., Baldassari, S., Ailuno, G., Turrini, F., Alfei, S., and Caviglioli, G. (2020). Formulation Strategies to Improve Oral Bioavailability of Ellagic Acid. Appl. Sci., 10.","DOI":"10.20944\/preprints202004.0100.v1"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Boggia, R., Turrini, F., Villa, C., Lacapra, C., Zunin, P., and Parodi, B. (2016). Green Extraction from Pomegranate Marcs for the Production of Functional Foods and Cosmetics. Pharmaceuticals, 9.","DOI":"10.3390\/ph9040063"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Boggia, R., Turrini, F., Roggeri, A., Olivero, G., Cisani, F., Bonfiglio, T., Summa, M., Grilli, M., Caviglioli, G., and Alfei, S. (2020). Neuroinflammation in Aged Brain: Impact of the Oral Administration of Ellagic Acid Microdispersion. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103631"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1039\/C8NJ05657A","article-title":"Preparation of Ellagic Acid Micro and Nano Formulations with Amazingly Increased Water Solubility by Its Entrapment in Pectin or Non-PAMAM Dendrimers Suitable for Clinical Applications","volume":"43","author":"Alfei","year":"2019","journal-title":"New J. Chem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/bph.13630","article-title":"Proanthocyanidins and Hydrolysable Tannins: Occurrence, Dietary Intake and Pharmacological Effects","volume":"174","author":"Smeriglio","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/jf103894m","article-title":"UV and MS Identification of Urolithins and Nasutins, the Bioavailable Metabolites of Ellagitannins and Ellagic Acid in Different Mammals","volume":"59","author":"Truchado","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1021\/jf5024615","article-title":"Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status","volume":"62","author":"Selma","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"453892","DOI":"10.1155\/2010\/453892","article-title":"Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis","volume":"2010","author":"Kaneto","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/tx500065y","article-title":"Ellagic Acid: An Unusually Versatile Protector against Oxidative Stress","volume":"27","author":"Galano","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-food-041715-033206","article-title":"Food Antioxidants: Chemical Insights at the Molecular Level","volume":"7","author":"Galano","year":"2016","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Francenia Santos-S\u00e1nchez, N., Salas-Coronado, R., Villanueva-Ca\u00f1ongo, C., and Hern\u00e1ndez-Carlos, B. (2019). Antioxidant Compounds and Their Antioxidant Mechanism. Antioxidants, IntechOpen.","DOI":"10.5772\/intechopen.85270"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1021\/acs.jpcb.5b04920","article-title":"N-Acetylserotonin and 6-Hydroxymelatonin against Oxidative Stress: Implications for the Overall Protection Exerted by Melatonin","volume":"119","author":"Galano","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3390\/molecules14062202","article-title":"Phenolics: From Chemistry to Biology","volume":"14","author":"Pereira","year":"2009","journal-title":"Molecules"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ptr.5643","article-title":"Prooxidant Activity of Polyphenols, Flavonoids, Anthocyanins and Carotenoids: Updated Review of Mechanisms and Catalyzing Metals","volume":"30","author":"Eghbaliferiz","year":"2016","journal-title":"Phytother. Res."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Alfei, S., Marengo, B., and Domenicotti, C. (2020). Polyester-Based Dendrimer Nanoparticles Combined with Etoposide Have an Improved Cytotoxic and Pro-Oxidant Effect on Human Neuroblastoma Cells. Antioxidants, 9.","DOI":"10.3390\/antiox9010050"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Olas, B. (2018). Berry Phenolic Antioxidants\u2014Implications for Human Health?. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00078"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1021\/jf072504n","article-title":"Berry Fruits for Cancer Prevention: Current Status and Future Prospects","volume":"56","author":"Seeram","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/advances\/nmab007","article-title":"Neuroprotective Potential of Ellagic Acid: A Critical Review","volume":"12","author":"Gupta","year":"2021","journal-title":"Adv. Nutr."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.foodchem.2006.08.010","article-title":"Isolation of Ellagic Acid from the Aqueous Extract of the Roots of Decalepis Hamiltonii: Antioxidant Activity and Cytoprotective Effect","volume":"103","author":"Srivastava","year":"2007","journal-title":"Food Chem."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jep.2014.03.017","article-title":"Evaluation of Anti-Inflammatory and Mechanism of Action of Extract of Macrosiphonia Longiflora (Desf.) M\u00fcll. Arg","volume":"154","author":"Almeida","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Jia, X., Luo, H., Xu, M., Zhai, M., Guo, Z., Qiao, Y., and Wang, L. (2018). Dynamic Changes in Phenolics and Antioxidant Capacity during Pecan (Carya illinoinensis) Kernel Ripening and Its Phenolics Profiles. Molecules, 23.","DOI":"10.3390\/molecules23020435"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1021\/acs.jafc.8b01181","article-title":"Identification and Characterization of Phenolic Compounds in Black Walnut Kernels","volume":"66","author":"Vu","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/0976-500X.103691","article-title":"Hepatoprotective Activity of Active Fractions of Thespesia Lampas Dalz and Gibs (Malvaceae)","volume":"3","author":"Subramoniam","year":"2012","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.foodres.2017.12.069","article-title":"Nutritional Potential, Chemical Profile and Antioxidant Activity of Chich\u00e1 (Sterculia striata) Nuts and Its by-Products","volume":"106","author":"Turcatto","year":"2018","journal-title":"Food Res. Int."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/09637486.2014.886181","article-title":"Antimicrobial Activities of Various Fractions of Longan (Dimocarpus longan Lour. Fen Ke) Seed Extract","volume":"65","author":"Tseng","year":"2014","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.apjtm.2017.10.030","article-title":"Polyphenolic Content, in Vitro Antioxidant Activity and Chemical Composition of Extract from Nephelium lappaceum L. (Mexican Rambutan) Husk","volume":"10","author":"Aguilar","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_214","first-page":"111","article-title":"Investigation into Biologically Active Constituents of Geum rivale L.","volume":"70","author":"Owczarek","year":"2013","journal-title":"Acta Pol. Pharm."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1631\/jzus.B1000117","article-title":"Evaluation of the Hepatoprotective and Antioxidant Activities of Rubus parvifolius L.","volume":"12","author":"Gao","year":"2011","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1080\/13880209.2017.1357736","article-title":"Bioactivity-Guided Isolation and Identification of Anti-Adipogenic Compounds from Sanguisorba officinalis","volume":"55","author":"Im","year":"2017","journal-title":"Pharm. Biol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"100499","DOI":"10.1016\/j.conctc.2019.100499","article-title":"Clinical Evaluation of Emblica Officinalis Gatertn (Amla) in Healthy Human Subjects: Health Benefits and Safety Results from a Randomized, Double-Blind, Crossover Placebo-Controlled Study","volume":"17","author":"Kapoor","year":"2020","journal-title":"Contemp. Clin. Trials Commun."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Navarro, M., Moreira, I., Arnaez, E., Quesada, S., Azofeifa, G., Vargas, F., Alvarado, D., and Chen, P. (2017). Flavonoids and Ellagitannins Characterization, Antioxidant and Cytotoxic Activities of Phyllanthus Acuminatus Vahl. Plants, 6.","DOI":"10.3390\/plants6040062"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.foodchem.2013.01.121","article-title":"Ellagic Acid Derivatives, Ellagitannins, Proanthocyanidins and Other Phenolics, Vitamin C and Antioxidant Capacity of Two Powder Products from Camu-Camu Fruit (Myrciaria dubia)","volume":"139","author":"Fracassetti","year":"2013","journal-title":"Food Chem."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Cuadrado-Silva, C., Pozo-Bay\u00f3n, M., and Osorio, C. (2016). Targeted Metabolomic Analysis of Polyphenols with Antioxidant Activity in Sour Guava (Psidium friedrichsthalianum Nied.) Fruit. Molecules, 22.","DOI":"10.3390\/molecules22010011"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13197-017-2944-6","article-title":"Phytochemical Composition, Antioxidant and Anti-Bacterial Activity of Syzygium Calophyllifolium Walp. Fruit","volume":"55","author":"Sathyanarayanan","year":"2018","journal-title":"J. Food Sci. Technol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1007\/s13197-017-2756-8","article-title":"Antidiabetic and Antioxidant Functionality Associated with Phenolic Constituents from Fruit Parts of Indigenous Black Jamun (Syzygium cumini L.) Landraces","volume":"54","author":"Gajera","year":"2017","journal-title":"J. Food Sci. Technol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.foodchem.2017.12.053","article-title":"Chemical Characterization of Myrciaria Floribunda (H. West Ex Willd) Fruit","volume":"248","author":"Porte","year":"2018","journal-title":"Food Chem."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Falc\u00e3o, T.R., de Ara\u00fajo, A.A., Soares, L.A.L., de Moraes Ramos, R.T., Bezerra, I.C.F., Ferreira, M.R.A., de Souza Neto, M.A., Melo, M.C.N., de Ara\u00fajo, R.F., and de Aguiar Guerra, A.C.V. (2018). Crude Extract and Fractions from Eugenia Uniflora Linn Leaves Showed Anti-Inflammatory, Antioxidant, and Antibacterial Activities. BMC Complement. Altern. Med., 18.","DOI":"10.1186\/s12906-018-2144-6"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1007\/s00216-018-0914-0","article-title":"Establishment of Pressurized-Liquid Extraction by Response Surface Methodology Approach Coupled to HPLC-DAD-TOF-MS for the Determination of Phenolic Compounds of Myrtle Leaves","volume":"410","author":"Ferranti","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3389\/fphar.2017.00466","article-title":"Leaf and Root Extracts from Campomanesia Adamantium (Myrtaceae) Promote Apoptotic Death of Leukemic Cells via Activation of Intracellular Calcium and Caspase-3","volume":"8","author":"Campos","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Puig, C.G., Reigosa, M.J., Valent\u00e3o, P., Andrade, P.B., and Pedrol, N. (2018). Unravelling the Bioherbicide Potential of Eucalyptus Globulus Labill: Biochemistry and Effects of Its Aqueous Extract. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192872"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Phan, A.D.T., Chaliha, M., Sultanbawa, Y., and Netzel, M.E. (2019). Nutritional Characteristics and Antimicrobial Activity of Australian Grown Feijoa (Acca sellowiana). Foods, 8.","DOI":"10.3390\/foods8090376"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jep.2013.07.024","article-title":"Both Plants Sebastiania Chamaelea from Niger and Chrozophora Senegalensis from Senegal Used in African Traditional Medicine in Malaria Treatment Share a Same Active Principle","volume":"149","author":"Moussa","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.15171\/apb.2016.039","article-title":"Anti-Inflammatory and Antioxidant Activity of Acalypha Hispida Leaf and Analysis of Its Major Bioactive Polyphenols by HPLC","volume":"6","author":"Siraj","year":"2016","journal-title":"Adv. Pharm. Bull."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4103\/pr.pr_124_16","article-title":"Bioassay-Guided In Vitro Study of the Antimicrobial and Cytotoxic Properties of the Leaves from Excoecaria Lucida Sw","volume":"9","author":"Beaven","year":"2017","journal-title":"Pharmacogn. Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0043-120447","article-title":"Polyphenols from Euphorbia Pekinensis Inhibit AGEs Formation In Vitro and Vessel Dilation in Larval Zebrafish In Vivo","volume":"84","author":"Lee","year":"2018","journal-title":"Planta Med."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s12272-013-0307-z","article-title":"Simultaneous Analysis and Peroxynitrite-Scavenging Activity of Galloylated Flavonoid Glycosides and Ellagic Acid in Euphorbia Supina","volume":"37","author":"Nugroho","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1021\/jf1048386","article-title":"Oral Administration of Trapa Taiwanensis Nakai Fruit Skin Extracts Conferring Hepatoprotection from CCl4-Caused Injury","volume":"59","author":"Wang","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0974-8490.178649","article-title":"Chromatographic Profiling of Ellagic Acid in Woodfordia Fruticosa Flowers and Their Gastroprotective Potential in Ethanol-Induced Ulcers in Rats","volume":"8","author":"Syed","year":"2016","journal-title":"Pharmacogn. Res."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jep.2018.02.038","article-title":"Lafoensia Pacari A. St.-Hil.: Wound Healing Activity and Mechanism of Action of Standardized Hydroethanolic Leaves Extract","volume":"219","author":"Pereira","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Park, S.W., Kwon, M.J., Yoo, J.Y., Choi, H.-J., and Ahn, Y.-J. (2014). Antiviral Activity and Possible Mode of Action of Ellagic Acid Identified in Lagerstroemia Speciosa Leaves toward Human Rhinoviruses. BMC Complement. Altern. Med., 14.","DOI":"10.1186\/1472-6882-14-171"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21010\/ajtcam.v14i4.3","article-title":"Neuroprotective Effect of Terminalia Chebula Extracts and Ellagic Acid in PC12 Cells","volume":"14","author":"Shen","year":"2017","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.sajb.2019.12.010","article-title":"Antioxidant and Antidiabetic Activities of Terminalia Bellirica Fruit in Alloxan Induced Diabetic Rats","volume":"130","author":"Gupta","year":"2020","journal-title":"South. Afr. J. Bot."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"226","DOI":"10.14393\/BJ-v32n1a2016-30208","article-title":"Comparison of Antioxidant and Antimicrobial Activities of Two Cultivated Cistus Species from Tunisia","volume":"32","author":"Mahmoudi","year":"2016","journal-title":"Biosci. J."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.foodchem.2013.09.012","article-title":"Polyphenols in Barringtonia Racemosa and Their Protection against Oxidation of LDL, Serum and Haemoglobin","volume":"146","author":"Kong","year":"2014","journal-title":"Food Chem."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/pca.2429","article-title":"Ellagic Acid and Derivatives from Cochlospermum Angolensis Welw. Extracts: HPLC\u2013DAD\u2013ESI\/MSnProfiling, Quantification and In Vitro Anti-depressant, Anti-cholinesterase and Anti-oxidant Activities","volume":"24","author":"Ferreres","year":"2013","journal-title":"Phytochem. Anal."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Krishnappa, P., Venkatarangaiah, K., Shivamogga Rajanna, S.K., and Kashi Prakash Gupta, R. (2014). Antioxidant and Prophylactic Effects of Delonix elata L., Stem Bark Extracts, and Flavonoid Isolated Quercetin against Carbon Tetrachloride-Induced Hepatotoxicity in Rats. Biomed. Res. Int., 2014.","DOI":"10.1155\/2014\/507851"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"3874516","DOI":"10.1155\/2016\/3874516","article-title":"Investigation of the Key Pharmacological Activities of Ficus Racemosa and Analysis of Its Major Bioactive Polyphenols by HPLC-DAD","volume":"2016","author":"Sumi","year":"2016","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1615\/JEnvironPatholToxicolOncol.v30.i3.10","article-title":"Hepatoprotection of Gentiana Scabra Extract and Polyphenols in Liver of Carbon Tetrachloride-Intoxicated Mice","volume":"30","author":"Ko","year":"2011","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.3390\/ijms12128740","article-title":"Chromatographic Fingerprint and the Simultaneous Determination of Five Bioactive Components of Geranium Carolinianum L. Water Extract by High Performance Liquid Chromatography","volume":"12","author":"Wu","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1021\/jf302703u","article-title":"Ultra High-Performance Liquid Chromatography with High-Resolution Mass Spectrometry Analysis of African Mango (Irvingia gabonensis) Seeds, Extract, and Related Dietary Supplements","volume":"60","author":"Sun","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Ala\u00f1\u00f3n, M.E., Palomo, I., Rodr\u00edguez, L., Fuentes, E., Arr\u00e1ez-Rom\u00e1n, D., and Segura-Carretero, A. (2019). Antiplatelet Activity of Natural Bioactive Extracts from Mango (Mangifera indica L.) and Its By-Products. Antioxidants, 8.","DOI":"10.3390\/antiox8110517"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Baldisserotto, A., Buso, P., Radice, M., Dissette, V., Lampronti, I., Gambari, R., Manfredini, S., and Vertuani, S. (2018). Moringa Oleifera Leaf Extracts as Multifunctional Ingredients for \u201cNatural and Organic\u201d Sunscreens and Photoprotective Preparations. Molecules, 23.","DOI":"10.3390\/molecules23030664"},{"key":"ref_250","unstructured":"Abbas, R.K., Al-Mushhin, A.A., Elsharbasy, F.S., and Ashiry, K.O. (2020). Reduce the Risk of Oxidation and Pathogenic Bacteria Activity by Moringa Oleifera Different Leaf Extract Grown in Sudan. J. Microb. Biochem. Technol., 12."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Tran, T.T., Kim, M., Jang, Y., Lee, H.W., Nguyen, H.T., Nguyen, T.N., Park, H.W., Le Dang, Q., and Kim, J.-C. (2017). Characterization and Mechanisms of Anti-Influenza Virus Metabolites Isolated from the Vietnamese Medicinal Plant Polygonum Chinense. BMC Complement. Altern. Med., 17.","DOI":"10.1186\/s12906-017-1675-6"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/jf034971k","article-title":"Fruit Maturity and Juice Extraction Influences Ellagic Acid Derivatives and Other Antioxidant Polyphenolics in Muscadine Grapes","volume":"52","author":"Lee","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/jf011500u","article-title":"Ellagic Acid and Flavonoid Antioxidant Content of Muscadine Wine and Juice","volume":"50","author":"Talcott","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpba.2014.07.013","article-title":"Metabolite Profiling of Polyphenols in the Tunisian Plant Tamarix aphylla (L.) Karst","volume":"99","author":"Mahfoudhi","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.14202\/vetworld.2019.1261-1265","article-title":"Effects of a Standardized 40% Ellagic Acid Pomegranate (Punica granatum L.) Extract on Seminiferous Tubule Histopathology, Diameter, and Epithelium Thickness in Albino Wistar Rats after Heat Exposure","volume":"12","author":"Utomo","year":"2019","journal-title":"Vet. World"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Wang, D., \u00d6zen, C., Abu-Reidah, I.M., Chigurupati, S., Patra, J.K., Horbanczuk, J.O., J\u00f3\u017awik, A., Tzvetkov, N.T., Uhrin, P., and Atanasov, A.G. (2018). Vasculoprotective Effects of Pomegranate (Punica granatum L.). Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00544"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/BF02977896","article-title":"\u03b2-Secretase(BACE1) Inhibitors from Pomegranate (Punica granatum) Husk","volume":"28","author":"Kwak","year":"2005","journal-title":"Arch. Pharm. Res."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3945\/jn.112.169516","article-title":"Pomegranate Polyphenols and Extract Inhibit Nuclear Factor of Activated T-Cell Activity and Microglial Activation In Vitro and in a Transgenic Mouse Model of Alzheimer Disease","volume":"143","author":"Rojanathammanee","year":"2013","journal-title":"J. Nutr."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2006.08.006","article-title":"Pomegranate Juice Decreases Amyloid Load and Improves Behavior in a Mouse Model of Alzheimer\u2019s Disease","volume":"24","author":"Hartman","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.foodres.2011.04.027","article-title":"Ellagitannins, Ellagic Acid and Their Derived Metabolites: A Review about Source, Metabolism, Functions and Health","volume":"44","author":"Landete","year":"2011","journal-title":"Food Res. Int."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"289","DOI":"10.17306\/J.AFS.2014.3.7","article-title":"The structure, occurrence and biological activity of ellagitannins: A general review","volume":"13","author":"Klewicka","year":"2014","journal-title":"Acta Sci. Pol. Technol. Aliment."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.foodres.2016.08.004","article-title":"Organic Acids in Kakadu Plum (Terminalia ferdinandiana): The Good (Ellagic), the Bad (Oxalic) and the Uncertain (Ascorbic)","volume":"89","author":"Williams","year":"2016","journal-title":"Food Res. Int."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.foodchem.2016.01.106","article-title":"Evaluation of Different Extraction Methods from Pomegranate Whole Fruit or Peels and the Antioxidant and Antiproliferative Activity of the Polyphenolic Fraction","volume":"202","author":"Masci","year":"2016","journal-title":"Food Chem."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/jf049450r","article-title":"Identification and Quantification of Phenolic Compounds in Berries of Fragaria and Rubus Species (Family rosaceae)","volume":"52","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtcme.2016.12.014","article-title":"Pharmacological Properties of Salvia Officinalis and Its Components","volume":"7","author":"Ghorbani","year":"2017","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/2225-4110.139107","article-title":"Pomegranate from Oman Alleviates the Brain Oxidative Damage in Transgenic Mouse Model of Alzheimer\u2019s disease","volume":"4","author":"Subash","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbrc.2009.10.130","article-title":"Ellagic Acid Promotes A\u03b242 Fibrillization and Inhibits A\u03b242-Induced Neurotoxicity","volume":"390","author":"Feng","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbb.2018.08.007","article-title":"Ellagic Acid: Insights into Its Neuroprotective and Cognitive Enhancement Effects in Sporadic Alzheimer\u2019s Disease","volume":"175","author":"Jha","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.biopha.2018.10.024","article-title":"Ellagic Acid Reveals Promising Anti-Aging Effects against d-Galactose-Induced Aging on Human Neuroblastoma Cell Line, SH-SY5Y: A Mechanistic Study","volume":"108","author":"Rahimi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biopha.2008.07.093","article-title":"Effect of Ellagic Acid on Proliferation, Cell Adhesion and Apoptosis in SH-SY5Y Human Neuroblastoma Cells","volume":"63","author":"Fjaeraa","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2015.10.008","article-title":"Altered Sensitivity to Ellagic Acid in Neuroblastoma Cells Undergoing Differentiation with 12-O-Tetradecanoylphorbol-13-Acetate and All-Trans Retinoic Acid","volume":"76","author":"Alfredsson","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jcb.21452","article-title":"Inhibition of Cadmium-induced Oxidative Injury in Rat Primary Astrocytes by the Addition of Antioxidants and the Reduction of Intracellular Calcium","volume":"103","author":"Yang","year":"2008","journal-title":"J. Cell Biochem."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/cn500214k","article-title":"Ellagic Acid Mitigates SNO-PDI Induced Aggregation of Parkinsonian Biomarkers","volume":"5","author":"Kabiraj","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1139\/apnm-2016-0651","article-title":"Ellagic Acid Protects against Neuron Damage in Ischemic Stroke through Regulating the Ratio of Bcl-2\/Bax Expression","volume":"42","author":"Liu","year":"2017","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.freeradbiomed.2010.10.693","article-title":"Oxidatively Generated DNA Damage after Cu(II) Catalysis of Dopamine and Related Catecholamine Neurotransmitters and Neurotoxins: Role of Reactive Oxygen Species","volume":"50","author":"Spencer","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Rizk, H.A., Masoud, M.A., and Maher, O.W. (2017). Prophylactic Effects of Ellagic Acid and Rosmarinic Acid on Doxorubicin-induced Neurotoxicity in Rats. J. Biochem. Mol. Toxicol., 31.","DOI":"10.1002\/jbt.21977"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2018.02.022","article-title":"The Possible Neuroprotective Effect of Ellagic Acid on Sodium Arsenate-Induced Neurotoxicity in Rats","volume":"198","author":"Goudarzi","year":"2018","journal-title":"Life Sci."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.toxrep.2018.02.017","article-title":"Ellagic Acid Attenuates Arsenic Induced Neuro-Inflammation and Mitochondrial Dysfunction Associated Apoptosis","volume":"5","author":"Firdaus","year":"2018","journal-title":"Toxicol. Rep."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/01616412.2019.1576319","article-title":"Neuroprotective Effects of Ellagic Acid against Acrylamide-Induced Neurotoxicity in Rats","volume":"41","author":"Goudarzi","year":"2019","journal-title":"Neurol. Res."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jbt.20030","article-title":"The Modulatory Effects of Ellagic Acid and Vitamin E Succinate on TCDD-induced Oxidative Stress in Different Brain Regions of Rats after Subchronic Exposure","volume":"18","author":"Hassoun","year":"2004","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15287390500246431","article-title":"The Effects of Ellagic Acid and Vitamin E Succinate on Antioxidant Enzymes Activities and Glutathione Levels in Different Brain Regions of Rats After Subchronic Exposure to TCDD","volume":"69","author":"Hassoun","year":"2006","journal-title":"J. Toxicol. Environ. Health A"},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Aslan, A., Gok, O., Beyaz, S., Arslan, E., Erman, O., and A\u011fca, C.A. (2020). The Preventive Effect of Ellagic Acid on Brain Damage in Rats via Regulating of Nrf-2, NF-kB and Apoptotic Pathway. J. Food Biochem., 44.","DOI":"10.1111\/jfbc.13217"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3109\/13880209.2015.1137601","article-title":"Beneficial Effects of Ellagic Acid against Animal Models of Scopolamine- and Diazepam-Induced Cognitive Impairments","volume":"54","author":"Mansouri","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_284","first-page":"83","article-title":"Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson\u2019s Disease","volume":"6","author":"Farbood","year":"2015","journal-title":"Basic. Clin. Neurosci."},{"key":"ref_285","first-page":"494","article-title":"Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson\u2019s Disease","volume":"54","author":"Sarkaki","year":"2016","journal-title":"Acta Med. Iran."},{"key":"ref_286","first-page":"38","article-title":"Ellagic Acid Improves Hyperalgesia and Cognitive Deficiency in 6-Hydroxidopamine Induced Rat Model of Parkinson\u2019s Disease","volume":"18","author":"Dolatshahi","year":"2015","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2017.02.021","article-title":"Ellagic Acid Exerts Protective Effect in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson\u2019s Disease: Possible Involvement of ER\u03b2\/Nrf2\/HO-1 Signaling","volume":"1662","author":"Baluchnejadmojarad","year":"2017","journal-title":"Brain Res."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0161-813X(02)00214-0","article-title":"Perinatal Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Activity-Dependent Expression of BDNF mRNA in the Neocortex and Male Rat Sexual Behavior in Adulthood","volume":"24","author":"Kakeyama","year":"2003","journal-title":"Neurotoxicology"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11011-019-00502-4","article-title":"Nanoformulated Ellagic Acid Ameliorates Pentylenetetrazol-Induced Experimental Epileptic Seizures by Modulating Oxidative Stress, Inflammatory Cytokines and Apoptosis in the Brains of Male Mice","volume":"35","author":"Othman","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"Chen, P., Chen, F., and Zhou, B. (2018). Antioxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Ellagic Acid in Liver and Brain of Rats Treated by D-Galactose. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-19732-0"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10072-011-0775-1","article-title":"Ellagic Acid Attenuates Oxidative Stress on Brain and Sciatic Nerve and Improves Histopathology of Brain in Streptozotocin-Induced Diabetic Rats","volume":"33","author":"Uzar","year":"2012","journal-title":"Neurol. Sci."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00210-018-1524-2","article-title":"Ellagic Acid Prevents Dementia through Modulation of PI3-Kinase-Endothelial Nitric Oxide Synthase Signalling in Streptozotocin-Treated Rats","volume":"391","author":"Kumar","year":"2018","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_293","first-page":"1153","article-title":"Ellagic Acid Improves Electrocardiogram Waves and Blood Pressure against Global Cerebral Ischemia Rat Experimental Models","volume":"7","author":"Nejad","year":"2015","journal-title":"Electron. Physician"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000502401","article-title":"Pharmacodynamic Effect of Ellagic Acid on Ameliorating Cerebral Ischemia\/Reperfusion Injury","volume":"104","author":"Wang","year":"2019","journal-title":"Pharmacology"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2015.01.013","article-title":"Ellagic Acid Prevents Cognitive and Hippocampal Long-Term Potentiation Deficits and Brain Inflammation in Rat with Traumatic Brain Injury","volume":"124","author":"Farbood","year":"2015","journal-title":"Life Sci."},{"key":"ref_296","first-page":"399","article-title":"Therapeutic Effects of Ellagic Acid on Memory, Hippocampus Electrophysiology Deficits, and Elevated TNF-\u03b1 Level in Brain Due to Experimental Traumatic Brain Injury","volume":"20","author":"Mashhadizadeh","year":"2017","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2012.02.034","article-title":"Evidence for the Involvement of the Monoaminergic System, but Not the Opioid System in the Antidepressant-like Activity of Ellagic Acid in Mice","volume":"682","author":"Girish","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1080\/14786419.2017.1385021","article-title":"The Antidepressant-like Activity of Ellagic Acid and Its Effect on Hippocampal Brain Derived Neurotrophic Factor Levels in Mouse Depression Models","volume":"32","author":"Bedel","year":"2018","journal-title":"Nat. Prod. Res."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2013.04.003","article-title":"Involvement of the GABAergic System in the Anxiolytic-like Effect of the Flavonoid Ellagic Acid in Mice","volume":"710","author":"Girish","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00213-017-4589-6","article-title":"Ellagic Acid Ameliorates Learning and Memory Deficits in a Rat Model of Alzheimer\u2019s Disease: An Exploration of Underlying Mechanisms","volume":"234","author":"Kiasalari","year":"2017","journal-title":"Psychopharmacology"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"e37372","DOI":"10.1016\/j.heliyon.2024.e37372","article-title":"Ellagic Acid Improves the Symptoms of Early-Onset Alzheimer\u2019s Disease: Behavioral and Physiological Correlates","volume":"10","author":"Jha","year":"2024","journal-title":"Heliyon"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1734-1140(12)70875-7","article-title":"Antidepressant-like Activity of Ellagic Acid in Unstressed and Acute Immobilization-Induced Stressed Mice","volume":"64","author":"Dhingra","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current Understanding of Metal Ions in the Pathogenesis of Alzheimer\u2019s Disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_305","unstructured":"(2024, September 30). PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/2\/844\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:32:18Z","timestamp":1759919538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/2\/844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":305,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["ijms26020844"],"URL":"https:\/\/doi.org\/10.3390\/ijms26020844","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]}}}